Global Health (MEDANTA) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
27 Aug, 2025Executive summary
Approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2024.
Board approved construction of service apartments/guest house at Medanta campus with Rs 250 Cr capex to enhance patient experience.
Notice issued for the 20th Annual General Meeting to be held on September 19, 2024.
Financial highlights
Standalone revenue from operations for Q1 FY25 was ₹6,114.49 million, up from ₹5,505.07 million in Q1 FY24.
Standalone profit after tax for Q1 FY25 was ₹962.84 million, compared to ₹862.12 million in Q1 FY24.
Consolidated revenue from operations for Q1 FY25 was ₹8,610.77 million, up from ₹7,795.80 million in Q1 FY24.
Consolidated profit after tax for Q1 FY25 was ₹1,062.86 million, compared to ₹1,020.10 million in Q1 FY24.
Outlook and guidance
Expansion with new service apartments/guest house at Gurgaon campus to support growing international and domestic patient demand.
Latest events from Global Health
- Q3 FY26 saw 19% revenue growth, strong expansion, and stable margins amid regulatory changes.MEDANTA
Q3 25/265 Feb 2026 - Double-digit growth and robust expansion, with new hospitals and strong patient volume momentum.MEDANTA
Q3 24/2520 Dec 2025 - Record Q1 growth in revenue, profit, and expansion, with dividend and new projects approved.MEDANTA
Q1 25/2623 Nov 2025 - 13% revenue growth, major expansion, and first dividend mark a strong FY2025.MEDANTA
Q4 24/2518 Nov 2025 - Q2 FY2026 delivered double-digit growth, major expansion, and strong cash flows.MEDANTA
Q2 25/2610 Nov 2025 - Strong Q2 and H1 FY25 growth, new incentive plan, and expansion with a new hospital agreement.MEDANTA
Q2 24/2527 Aug 2025